Navigation Links
Jack Anthony to Resign From VaxGen's Board After Accepting CEO Position at Osprey Pharmaceuticals
Date:9/28/2007

SOUTH SAN FRANCISCO, Calif., Sept. 28 /PRNewswire-FirstCall/ -- VaxGen, Inc. (Pink Sheets: VXGN) announced today that Jack Anthony has resigned from the company's Board of Directors as a result of accepting the CEO position at Osprey Pharmaceuticals. The Osprey Board has required that Mr. Anthony relinquish all corporate directorships in accepting this position. Mr. Anthony's resignation is effective immediately.

(Logo: http://www.newscom.com/cgi-bin/prnh/19991112/VAXGENLOGO)

"On behalf of VaxGen's directors and officers, I want to thank Jack for his service to the company and its stockholders, and for his many contributions to our efforts in pursuit of a strategic transaction," said James P. Panek, VaxGen's President and CEO. "Since his appointment to the Board in May, Jack has lent his active and expert assistance in helping us formulate and consider various strategic alternatives. We wish him the very best, and know that he will be a tremendous asset to Osprey." VaxGen continues to seek qualified independent director candidates who will contribute to its efforts in pursuit of strategic alternatives.

About VaxGen

VaxGen is a biopharmaceutical company based in Brisbane, California. For more information, please visit the company's web site at http://www.vaxgen.com.

Note: This press release contains "forward-looking statements" within the meaning of the federal securities laws. These forward-looking statements include without limitation, statements regarding the anticipated filing of the company's outstanding quarterly reports and its application for listing of its common stock. These statements are subject to risks and uncertainties that could cause actual results and events to differ materially from those anticipated. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date of this release. VaxGen undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date of this release except as required by law.


'/>"/>
SOURCE VaxGen, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. JT Packard exec resigns after settling copyright disputes
2. Donley resigns as WiCell director
3. UWM accepts resignation of research dean
4. Renaissance Learning CEO resigns to start company
5. Chemical-petroleum executive joins Virent Energy board
6. Schneider National exec joins TrafficCast board
7. Ethics Board site offers welcome contrast to state IT mistakes
8. Genomics researcher Hood joins NimbleGen board
9. Corporate control begins with a strong board
10. Kyron appoints former AMA chairman to board
11. Online service makes board connections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... ... the full spectrum of drug and device development, and Prism Clinical Research ... and clinicians, today announced Verified Clinical Trials (VCT) has been selected ...
(Date:1/19/2017)... BETHESDA, Md. , Jan. 18, 2017  Northwest ... company developing DCVax® personalized immune therapies for operable and ... Marnix Bosch , Chief Technical Officer of NW Bio, ... Thursday, January 19, 2017, at the Hyatt Regency Hotel ... Dr. Bosch will chair the session entitled "New Therapeutic ...
(Date:1/19/2017)... Jan. 18, 2017 BD (Becton, Dickinson and Company) (NYSE: ... that it will host a live webcast of its Annual Meeting ... The webcast can be accessed from the BD ... through Tuesday, January 31, 2017. ... About BD BD is a global medical ...
(Date:1/18/2017)... According to a new market research report "In situ Hybridization Market by Technique ... Diagnostic Laboratories, Academic and Research Institutions) - Global Forecast to 2021" published by ... USD 557.1 Million in 2016, growing at a CAGR of 5.8%. ... ... MarketsandMarkets Logo ...
Breaking Biology Technology:
(Date:1/11/2017)... 11, 2017  Michael Johnson, co-founder of Visikol Inc. a company ... has been named to the elite "Forbes 30 Under 30" list ... 600 people in 20 fields nationwide to be recognized as a ... applicants were selected. ... He is currently a PhD candidate at Rutgers University. ...
(Date:1/6/2017)... 5, 2017  Delta ID Inc., a leader in ... for automotive at CES® 2017. Delta ID has collaborated ... demonstrate the use of iris scanning as a secure, ... driver in a car, and as a way to ... Delta ID and Gentex will demonstrate (booth ...
(Date:1/3/2017)... 2017 Onitor, provider of digital health technology ... an innovative biometric data-driven program designed to aid weight ... the 2017 Consumer Electronics Show (CES) in ... U.S., the World Health Organization (WHO), have identified lifestyle ... who are overweight or obese. WHO also states that ...
Breaking Biology News(10 mins):